abstract |
The present invention relates to novel hepatic receptor X (LXR) modulators, their use in diagnosis and therapy, more particularly in the treatment of LXR receptor-associated diseases, such as cancer, inflammation, metabolic diseases and autoimmune diseases. -immunes. |